
Loading, please wait...

Loading, please wait...

This systematic review analyzed 87 studies on biomarkers in human angiosarcoma (AS), a rare vascular malignancy with poor prognosis. Key findings include recurrent mutations (TP53, POT1, MYC), disrupted signaling pathways (VEGF, PI3K/Akt/mTOR), and diagnostic protein markers (CD31, ERG). These molecular insights highlight potential avenues for improving AS diagnosis, prognosis, and targeted therapies.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


This systematic review analyzed 87 studies on biomarkers in human angiosarcoma (AS), a rare vascular malignancy with poor prognosis. Key findings include recurrent mutations (TP53, POT1, MYC), disrupted signaling pathways (VEGF, PI3K/Akt/mTOR), and diagnostic protein markers (CD31, ERG). These molecular insights highlight potential avenues for improving AS diagnosis, prognosis, and targeted therapies.
last month

A breakthrough study using human colonic organoids demonstrates that bacterial serine protease EspP, an EHEC cytotoxin, halts epithelial proliferation and preferentially triggers enteroendocrine cell differentiation, promoting pro-inflammatory chemokine release and immune cell recruitment.
2 days back

Recent research reveals that downregulating YAP1/TAZ-TEAD via Hippo signaling triggers spontaneous human trophoblast syncytialization in 3D cultures, illuminating placental biology and preeclampsia.
2 days back

A landmark comparative study evaluates atrial electrophysiology across humans, swine, and rodents. By linking cellular recordings with transcriptomics and in silico modeling, researchers resolve cross-species gaps, explaining translational failures to advance targeted therapies for atrial arrhythmias.
2 days back

A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
4 weeks back

Researchers have developed an innovative ultrasound-responsive nano-contrast agent that co-delivers CIITA-siRNA and rapamycin directly to inflamed thyroid tissue, significantly reducing autoimmune injury and thyroid autoantibodies in preclinical models of Hashimoto thyroiditis.
2 days back